A comparative study to evaluate the therapeutic effects of nutraceuticals in oral leukoplakia:- A randomized clinical trail

Tanveer Ahmad, Imran Khan, Asia Sultana, M. Moshahid A. Rizvi
{"title":"A comparative study to evaluate the therapeutic effects of nutraceuticals in oral leukoplakia:- A randomized clinical trail","authors":"Tanveer Ahmad, Imran Khan, Asia Sultana, M. Moshahid A. Rizvi","doi":"10.4103/njms.njms_25_23","DOIUrl":null,"url":null,"abstract":"Background: Oral leukoplakia, usually white changes in the oral mucosa, is one of the most common conditions affecting the oral cavity. Oral leukoplakia can occur anywhere in the mouth and is usually asymptomatic. Clinical diagnosis is reliant on visual inspection and manual palpation. It has a global prevalence of 2.6% and a malignant transformation rate of 0.13–34%. In India, OL has a higher prevalence (0.2–5.2%) but a lower a malignant transformation rate (0.13–10%). Methodology: It was a randomized control trial in which study was conducted on clinically diagnosed 300 oral leukoplakia patients. All patients were randomly categorized in three groups of 100 each. Group-A: Patients were given commercially available curcumin 500 mg. daily orally. Group-B: Patients were given 4 mg of oral lycopene daily. Group-C: Patients were treated with 4 mg of lycopene + 500 mg curcumin daily by oral route. After recording the pre-treatment clinical findings, all the participants were evaluated regularly after 30 days, 60 days and 90 days of active treatment and once in a month for another 3 months of post-treatment follow-up and to evaluate concomitant medication, lesion(s), compliance, and adverse events. The clinical response was evaluated by bi-dimensional measurement of the lesions and color photography. Safety assessment measures: Physical examination and laboratory tests were performed at baseline, and every 30 days for 3 months after randomization. Result: Number of participants cured after treatment with oral curcumin was 51%. Participants took lycopene tablets showed 63% cure rate and 72% participants cured after treatment with combination curcumin and lycopene. Conclusion: Results showed that curcumin, lycopene, and a combination of the two are effective in the treatment of oral leukoplakia. When compared, we found that lycopene is a better nutraceutical as compared to curcumin. When both nutraceuticals were given to the participants, they showed better results than single nutraceuticals when the data were analyzed after 90 days of treatment. There is a significant difference in the response of curcumin and combinations of both nutraceuticals, although the difference between lycopene and combinations of curcumin and lycopene is insignificant.","PeriodicalId":18827,"journal":{"name":"National Journal of Maxillofacial Surgery","volume":"53 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"National Journal of Maxillofacial Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/njms.njms_25_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Oral leukoplakia, usually white changes in the oral mucosa, is one of the most common conditions affecting the oral cavity. Oral leukoplakia can occur anywhere in the mouth and is usually asymptomatic. Clinical diagnosis is reliant on visual inspection and manual palpation. It has a global prevalence of 2.6% and a malignant transformation rate of 0.13–34%. In India, OL has a higher prevalence (0.2–5.2%) but a lower a malignant transformation rate (0.13–10%). Methodology: It was a randomized control trial in which study was conducted on clinically diagnosed 300 oral leukoplakia patients. All patients were randomly categorized in three groups of 100 each. Group-A: Patients were given commercially available curcumin 500 mg. daily orally. Group-B: Patients were given 4 mg of oral lycopene daily. Group-C: Patients were treated with 4 mg of lycopene + 500 mg curcumin daily by oral route. After recording the pre-treatment clinical findings, all the participants were evaluated regularly after 30 days, 60 days and 90 days of active treatment and once in a month for another 3 months of post-treatment follow-up and to evaluate concomitant medication, lesion(s), compliance, and adverse events. The clinical response was evaluated by bi-dimensional measurement of the lesions and color photography. Safety assessment measures: Physical examination and laboratory tests were performed at baseline, and every 30 days for 3 months after randomization. Result: Number of participants cured after treatment with oral curcumin was 51%. Participants took lycopene tablets showed 63% cure rate and 72% participants cured after treatment with combination curcumin and lycopene. Conclusion: Results showed that curcumin, lycopene, and a combination of the two are effective in the treatment of oral leukoplakia. When compared, we found that lycopene is a better nutraceutical as compared to curcumin. When both nutraceuticals were given to the participants, they showed better results than single nutraceuticals when the data were analyzed after 90 days of treatment. There is a significant difference in the response of curcumin and combinations of both nutraceuticals, although the difference between lycopene and combinations of curcumin and lycopene is insignificant.
评价营养品治疗口腔白斑疗效的比较研究:一项随机临床试验
背景:口腔白斑,通常是口腔黏膜的白色变化,是影响口腔最常见的疾病之一。口腔白斑可以发生在口腔的任何地方,通常是无症状的。临床诊断依赖于目视检查和手触诊。全球患病率为2.6%,恶性转化率为0.13-34%。在印度,OL的患病率较高(0.2-5.2%),但恶性转化率较低(0.13-10%)。方法:随机对照试验,对临床诊断为口腔白斑的300例患者进行研究。所有患者随机分为三组,每组100人。a组:给予市售姜黄素500 mg。日常口头。b组:患者每日口服番茄红素4mg。c组:每日口服番茄红素4mg +姜黄素500mg。在记录治疗前临床表现后,所有参与者在积极治疗30天、60天和90天后定期接受评估,并在治疗后随访3个月,每月一次,评估伴随用药情况、病变情况、依从性和不良事件。临床反应通过病变的二维测量和彩色摄影来评估。安全评价措施:在基线时进行体格检查和实验室检查,随机分组后3个月内每30天进行一次检查。结果:口服姜黄素治疗后治愈的人数为51%。服用番茄红素片的患者治愈率为63%,服用姜黄素和番茄红素联合治疗的患者治愈率为72%。结论:姜黄素、番茄红素联合应用治疗口腔白斑有较好的疗效。通过比较,我们发现番茄红素比姜黄素具有更好的营养价值。当两种营养品都给参与者时,在治疗90天后分析数据时,他们显示出比单一营养品更好的结果。尽管番茄红素与姜黄素和番茄红素的组合之间的差异不显著,但姜黄素和两种营养药物的组合在反应上存在显著差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信